Contact
searchSearch
HMP Global

Urticaria Topic Center

Research Highlights
Emerging Therapies for Chronic Spontaneous Urticaria
01/29/2026
Rebecca Mashaw
New biologic agents and small-molecule therapies expanding options beyond traditional antihistamines and omalizumab.
New biologic agents and small-molecule therapies expanding options beyond traditional antihistamines and omalizumab.
New biologic agents and...
01/29/2026
Allergy & Immunology
Research Review
Chronic Urticaria Linked to Autoinflammatory Syndromes
01/29/2026
Rebecca Mashaw
A recent review suggests that chronic urticaria may be a potential cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that chronic urticaria may be a potential cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that...
01/29/2026
Allergy & Immunology
Jonathan Bernstein, MD
Q&A
Jonathan Bernstein, MD, on Chronic Spontaneous Urticaria
01/20/2026
Jonathan A. Bernstein, MD
Allergist Jonathan Bernstein, MD, provided an in-depth review of diagnosing and treating chronic spontaneous urticaria.
Allergist Jonathan Bernstein, MD, provided an in-depth review of diagnosing and treating chronic spontaneous urticaria.
Allergist Jonathan Bernstein,...
01/20/2026
Allergy & Immunology
Clinical Review
Chronic Urticaria Linked to Autoinflammatory Syndromes
01/16/2026
Rebecca Mashaw
A recent review suggests that chronic urticaria may be a cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that chronic urticaria may be a cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that...
01/16/2026
Allergy & Immunology
News
Blastocystis Colonization Alters Gut Microbiota in Patients With Urticaria
12/06/2025
Jessica Garlewicz
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that...
12/06/2025
Allergy & Immunology
Population Analysis
Acute Urticaria Incidence Declined During COVID-19
12/06/2025
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
12/06/2025
Allergy & Immunology
Conference Coverage
Barriers Limit Allergy and Immunology Referrals in Pregnancy
11/14/2025
Rebecca Mashaw
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of...
11/14/2025
Allergy & Immunology
News
Povorcitinib Rapidly Reduces Hives and Itch in Chronic Spontaneous Urticaria
11/13/2025
Jessica Garlewicz
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized,...
11/13/2025
Allergy & Immunology

In the News

News
Blastocystis Colonization Alters Gut Microbiota in Patients With Urticaria
12/06/2025
Jessica Garlewicz
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that...
12/06/2025
Allergy & Immunology
News
Povorcitinib Rapidly Reduces Hives and Itch in Chronic Spontaneous Urticaria
11/13/2025
Jessica Garlewicz
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized,...
11/13/2025
Allergy & Immunology
Research Review
MDD in Asthma Patients Associated With Worse Outcomes in Older Adults
01/29/2026
Rebecca Mashaw
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by...
01/29/2026
Allergy & Immunology
Research Summary
Barriers to Normalization Persist for U.S. Patients With Hereditary Angioedema
01/18/2026
Rebecca Mashaw
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight...
01/18/2026
Allergy & Immunology
Comorbidities
Oscillometry-Based Markers Reveal Airway Dynamics in Asthma–OSA Overlap
12/06/2025
Jessica Garlewicz
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic...
12/06/2025
Allergy & Immunology
Morbidity & Mortality
Mortality From Coexisting Asthma and Cardiovascular Disease Rising
12/06/2025
Jessica Garlewicz
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant...
12/06/2025
Allergy & Immunology
Research Highlights
Elevated Comorbidity Burden and Surgical Interventions in Patients With HAE-C1INH
12/06/2025
Jessica Garlewicz
Study findings underscore the need for heightened clinical surveillance and early recognition to avoid unnecessary procedures and improve long-term patient outcomes.
Study findings underscore the need for heightened clinical surveillance and early recognition to avoid unnecessary procedures and improve long-term patient outcomes.
Study findings underscore the...
12/06/2025
Allergy & Immunology
Emerging Therapies
Advances in HAE Therapeutics Highlight Path Toward Personalized, Patient-Centered Care
12/06/2025
Jessica Garlewicz
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management...
12/06/2025
Allergy & Immunology
News
Blastocystis Colonization Alters Gut Microbiota in Patients With Urticaria
12/06/2025
Jessica Garlewicz
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that...
12/06/2025
Allergy & Immunology
News
Outpatient Study Highlights Effectiveness of Penicillin Allergy Delabeling via Oral Challenge
11/17/2025
Jessica Garlewicz
A retrospective chart review conducted at an outpatient allergy clinic found that oral drug challenges are safe and highly effective for penicillin allergy delabeling.
A retrospective chart review conducted at an outpatient allergy clinic found that oral drug challenges are safe and highly effective for penicillin allergy delabeling.
A retrospective chart review...
11/17/2025
Allergy & Immunology
News
Cephalosporin Allergy Evaluation Improves Antibiotic Stewardship in Immunocompromised Inpatients
11/17/2025
Jessica Garlewicz
A targeted inpatient allergy consult service employing risk stratification and drug provocation testing significantly improved antibiotic stewardship by safely de-labeling cephalosporin allergies in immunocompromised patients.
A targeted inpatient allergy consult service employing risk stratification and drug provocation testing significantly improved antibiotic stewardship by safely de-labeling cephalosporin allergies in immunocompromised patients.
A targeted inpatient allergy...
11/17/2025
Allergy & Immunology
News
Drug-Related Anaphylaxis Mortality Remains Stable but Disparities Persist
11/13/2025
Jessica Garlewicz
A new national analysis of death certificate data from 2011 to 2023 reveals that drug-related anaphylaxis continues to be a significant contributor to anaphylaxis-related deaths in the United States, particularly among older adults and...
A new national analysis of death certificate data from 2011 to 2023 reveals that drug-related anaphylaxis continues to be a significant contributor to anaphylaxis-related deaths in the United States, particularly among older adults and...
A new national analysis of death...
11/13/2025
Allergy & Immunology

Popular Articles

News
FDA Approves Budesonide Oral Suspension for EoE
02/28/2024
Rebecca Mashaw
The approval marks the first and only oral therapy for patients 11 and older with eosinophilic esophagitis.
The approval marks the first and only oral therapy for patients 11 and older with eosinophilic esophagitis.
The approval marks the first and...
02/28/2024
Gastroenterology
Allergen Focus
Photoallergic Contact Dermatitis
03/06/2024
Caroline Brumley, BS; Sara A. Hylwa, MD
Recognizing and testing for this rare but important photodermatosis are keys to alleviating patient distress.
Recognizing and testing for this rare but important photodermatosis are keys to alleviating patient distress.
Recognizing and testing for this...
03/06/2024
The Dermatologist
Population Analysis
Acute Urticaria Incidence Declined During COVID-19
12/06/2025
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
12/06/2025
Allergy & Immunology
Research Highlights
Dupilumab Shows Efficacy in Real-World Treatment of Eosinophilic Esophagitis
12/31/2025
Rebecca Mashaw
A meta-analysis pools data across multiple centers to show high rates of symptom resolution and histologic improvement among patients with EoE outside controlled trials.
A meta-analysis pools data across multiple centers to show high rates of symptom resolution and histologic improvement among patients with EoE outside controlled trials.
A meta-analysis pools data...
12/31/2025
Allergy & Immunology
Clinical Trials
Deucrictibant Demonstrates Durable Efficacy and Safety in Long-Term Prophylaxis of Hereditary Angioedema
11/13/2025
Jessica Garlewicz
Interim results from the open-label extension of the CHAPTER-1 phase 2 trial support the long-term efficacy and safety of deucrictibant, an oral bradykinin B2 receptor antagonist, for hereditary angioedema prophylaxis
Interim results from the open-label extension of the CHAPTER-1 phase 2 trial support the long-term efficacy and safety of deucrictibant, an oral bradykinin B2 receptor antagonist, for hereditary angioedema prophylaxis
Interim results from the...
11/13/2025
Allergy & Immunology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use